Date: Thursday, November 3, 2022 1:00PM - 2:00 PM ET
Topic: USP 797 A Review of the Final Revisions
An Exploration of USP Chapter 797 revisions and their impact on pharmacy regulatory and compliance efforts.
After feedback from stakeholders, USP is scheduled to publish their final revisions to chapters 797 and 795 on November 1st, 2022.
CPS invites you to meet with our Compliance and Regulatory Services pharmacist specialists as they review these highly anticipated compounding standards, with an emphasis on 797 and sterile compounding. These important standards will be a focus of CMS-accrediting organizations and state boards of pharmacy.
Audience members explored:
• USP 797 standards in this final revision and how they have changed since the last version was published
• Chapter highlights related to training and education, physical plant and equipment, and environmental monitoring
• Strategies for compliance with both USP 797 and 800 when they become enforceable
Member, The Joint Commission Pharmacy Advisory Council
SVP, Compliance & Regulatory Services
Consultant to Tennessee Board of Pharmacy Complaint Committee
Senior Director, Compliance & Regulatory Services